SPRB
Spruce Biosciences Inc.
$104.94
+$0.19(+0.18%)
55
Overall
60
Value
66
Tech
39
Quality
Market Cap
$70.10M
Volume
107.05K
52W Range
$0.06 - $240.00
Target Price
$207.00
Order:
Income Statement
| Metric | Trend | Chart | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Total Revenue | -- | -- | -- | $10.1M | $4.9M | ||
| Total Revenue | -- | -- | -- | $10.1M | $4.9M | ||
| GROSS PROFIT | |||||||
| Gross Profit | -- | -- | -- | $10.1M | $4.9M | ||
| OPERATING EXPENSES | |||||||
| Operating Expenses | $29.4M | $42.1M | $47.3M | $62.1M | $61.1M | ||
| Research & Development | $23.9M | $30.7M | $35.2M | $49.4M | $46.4M | ||
| Research Expense | $23.9M | $30.7M | $35.2M | $49.4M | $46.4M | ||
| Selling, General & Administrative | $5.6M | $11.4M | $12.1M | $12.7M | $14.6M | ||
| General & Administrative Expenses | $5.6M | $11.4M | $12.1M | $12.7M | $14.6M | ||
| Depreciation & Amortization | $5.0K | $23.0K | -- | -- | -- | ||
| Depreciation & Amortization | $5.0K | $23.0K | -- | -- | -- | ||
| Other Operating Expenses | $-686.0K | $-693.0K | $-1.4M | -- | -- | ||
| OPERATING INCOME | |||||||
| Operating income | $-29.4M | $-42.1M | $-47.3M | $-52.0M | $-56.2M | ||
| EBITDA | $-29.1M | $-41.9M | $-45.7M | $-47.4M | $-52.7M | ||
| NON-OPERATING ITEMS | |||||||
| Interest Expense (Non-Operating) | $323.0K | $345.0K | $420.0K | $483.0K | $307.0K | ||
| Intinc | -- | $119.0K | $1.5M | $4.6M | $3.4M | ||
| Net Non-Operating Interest Income/Expense | $-323.0K | $-226.0K | $1.1M | $4.1M | $3.1M | ||
| Other Income/Expense | $-200.0K | $-119.0K | $-750.0K | -- | -- | ||
| Other Special Charges | $200.0K | $119.0K | -- | -- | -- | ||
| PRE-TAX INCOME | |||||||
| EBIT | $-29.2M | $-41.9M | $-45.8M | $-47.4M | $-52.7M | ||
| Pre-Tax Income | $-29.5M | $-42.3M | $-46.2M | $-47.9M | $-53.0M | ||
| NET INCOME | |||||||
| Net Income | $-29.5M | $-42.3M | $-46.2M | $-47.9M | $-53.0M | ||
| Net Income (Continuing Operations) | $-29.5M | $-42.3M | $-46.2M | $-47.9M | $-53.0M | ||
| Net Income (Discontinued Operations) | $-29.5M | $-42.3M | $-46.2M | $-47.9M | $-53.0M | ||
| Net Income (Common Stockholders) | $-29.5M | $-42.3M | $-46.2M | $-47.9M | $-53.0M | ||
| Normalized Income | -- | -- | -- | -- | $-52.5M | ||
| TOTALS | |||||||
| Total Expenses | $29.4M | $42.1M | $47.3M | $62.1M | $61.1M | ||
| SHARE & EPS DATA | |||||||
| Average Shares Outstanding | $6.0M | $23.4M | $23.5M | $38.5M | $41.3M | ||
| Average Shares Outstanding (Diluted) | $6.0M | -- | $23.5M | $38.5M | $41.3M | ||
| Shares Outstanding | $23.3M | $23.5M | $39.7M | $41.1M | $42.2M | ||
| Basic EPS | $-4.93 | $-1.81 | $-1.96 | $-1.24 | $-1.29 | ||
| Basic EPS (Continuing Operations) | $-4.93 | $-1.81 | $-1.96 | $-1.24 | $-1.29 | ||
| Diluted EPS | $-4.93 | $-1.81 | $-1.96 | $-1.24 | $-1.29 | ||
| Diluted EPS (Continuing Operations) | -- | -- | $-1.96 | $-1.24 | $-1.29 | ||
| OTHER METRICS | |||||||
| Gain On Sale Of P P E | -- | -- | $750.0K | -- | -- | ||
| Other Gand A | $5.6M | $11.4M | $12.1M | $12.7M | $14.6M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SPRB | $104.94 | +0.2% | 107.05K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |